National Survey on Gastroesophageal Reflux Disease (GERD) Patients

The purpose of this observational study is to assess the impact of abdominal fat on severity and frequency of GERD symptoms .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

GERD Deglutition Disorders Digestive System Diseases Esophageal Diseases Esophageal Motility Disorders Gastroesophageal Reflux Gastrointestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, ARC ET Senans RC ET Senans, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or female > or = 18 years old
Patient with symptomatic GERD
Without PPI or H2 antagonist treatment during the 3 previous months
Agree to take part in this study

Exclusion criteria

Pregnant women

Treatment and study plan

Primary outcomes

Waist circumference

Time frame: Once

Secondary outcomes

Frequency of GERD symptoms

Time frame: Once
GERD impact scale

Time frame: Once

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Evaluation of the Impact of Abdominal Fat on GERD Severity and GERD Frequency in General Practice

Acronym: LINEA

Important dates

Study start: 2008
Study completion: 2008
First posted: Jun 12, 2008
Registry last updated: Aug 6, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed